Drug makers to face tough times

Published: 2008-09-29 07:00:00

Updated: 2008-09-29 07:00:00

Local pharmaceutical firms will face tough times ahead due to the government’s plan to reduce the drug prices depending on expected higher demand.

The Health Insurance Review and Assessment Service (HIRA) is expected to discuss the measure on September 26.

Sources say the domestic pharmaceu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK